MedTrace Logo

Evaluation of Personalised Support Program Effectiveness in Sperm Quality Improvement

NCT03475199 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2019-02-15

No results posted yet for this study

Summary

FabLife is an interventional, prospective, multicentre, controlled study undertaken in metropolitan France.

The main objective is to evaluate the effect of FabLife personalised program over a period of 15 weeks on the improvement of spermatic DNA fragmentation in subfertile men compared to general dietary recommendations.

Conditions

  • Male Infertility

Interventions

DEVICE

FabLife

* A personnalized dietary program depending on the patient's phenotype and genotype * The daily intake of a dietary supplement, developped in the context of male infertility.

Sponsors & Collaborators

  • Keyrus Biopharma

    collaborator OTHER

  • FabLife

    lead INDUSTRY

Principal Investigators

  • Rachel Levy, Md, PhD, Pr · Hopital Tenon (AP-HP) France

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-13
Primary Completion
2019-06-30
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03475199 on ClinicalTrials.gov